https://ir.definiumtx.com/news-events/press-releases/rss en-us https://d1io3yog0oux5.cloudfront.net/_354426f606269984c271309319e3bc85/mindmed/files/theme/images/logo-sm.png Equisolve Investor Relations Suite https://ir.definiumtx.com/news-events/press-releases/detail/228/definium-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference Thu, 21 May 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/228/definium-therapeutics-to-participate-in-the-2026-jefferies-global-healthcare-conference https://ir.definiumtx.com/news-events/press-releases/detail/227/definium-therapeutics-announces-first-patient-dosed-in-ascend-the-second-phase-3-pivotal-study-of-dt120-odt-in-major-depressive-disorder Tue, 12 May 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/227/definium-therapeutics-announces-first-patient-dosed-in-ascend-the-second-phase-3-pivotal-study-of-dt120-odt-in-major-depressive-disorder https://ir.definiumtx.com/news-events/press-releases/detail/226/definium-therapeutics-announces-new-employee-inducement-grants Mon, 11 May 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/226/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/225/definium-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights Thu, 07 May 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/225/definium-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights https://ir.definiumtx.com/news-events/press-releases/detail/224/definium-therapeutics-to-report-first-quarter-2026-financial-results-on-may-7-2026 Thu, 30 Apr 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/224/definium-therapeutics-to-report-first-quarter-2026-financial-results-on-may-7-2026 https://ir.definiumtx.com/news-events/press-releases/detail/223/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and-analyst-day Wed, 22 Apr 26 16:15:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/223/definium-therapeutics-highlights-dt120-odt-lysergide-tartrate-clinical-advancements-and-commercial-strategy-at-investor-and-analyst-day https://ir.definiumtx.com/news-events/press-releases/detail/222/definium-therapeutics-announces-new-employee-inducement-grants Mon, 20 Apr 26 16:01:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/222/definium-therapeutics-announces-new-employee-inducement-grants https://ir.definiumtx.com/news-events/press-releases/detail/221/definium-therapeutics-applauds-white-house-executive-order-to-accelerate-mental-health-innovation-and-expand-access-to-psychedelic-medical-treatments Sat, 18 Apr 26 19:38:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/221/definium-therapeutics-applauds-white-house-executive-order-to-accelerate-mental-health-innovation-and-expand-access-to-psychedelic-medical-treatments https://ir.definiumtx.com/news-events/press-releases/detail/220/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events Thu, 09 Apr 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/220/definium-therapeutics-to-participate-at-upcoming-investor-conferences-and-events https://ir.definiumtx.com/news-events/press-releases/detail/219/new-definium-therapeutics-study-published-in-the-journal-of-mood-and-anxiety-disorders-reveals-increasing-prevalence-and-burden-of-generalized-anxiety-disorder-in-the-united-states Tue, 31 Mar 26 07:00:00 -0400 https://ir.definiumtx.com/news-events/press-releases/detail/219/new-definium-therapeutics-study-published-in-the-journal-of-mood-and-anxiety-disorders-reveals-increasing-prevalence-and-burden-of-generalized-anxiety-disorder-in-the-united-states